istock-691511636_sanjeri
sanjeri / iStockphoto.com
13 July 2018Americas

LSIPR 50 2018: Personalised medicine: the way forward

Being part of a team that “discovers, develops, and delivers” transformational medicine is one of the reasons that Paul Golian’s job at Bristol-Myers Squibb (BMS) is so rewarding. Another is meeting patients that have benefited from the drugs he has worked on, something that makes him particularly proud.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
27 September 2018   While personalised medicine is a challenging area for drug developers, there are a number of potential solutions, as LSIPR finds out.

More on this story

Americas
27 September 2018   While personalised medicine is a challenging area for drug developers, there are a number of potential solutions, as LSIPR finds out.

More on this story

Americas
27 September 2018   While personalised medicine is a challenging area for drug developers, there are a number of potential solutions, as LSIPR finds out.